Purpose Hepatocellular carcinoma (HCC) is an aggressive disease with high recurrence
rate. However, current staging systems were lack of predictive capacity for HCC recurrence …

Background: This study developed a novel inflammation score system to predict survival
outcomes using preoperational inflammatory markers in hepatocellular carcinoma (HCC) …

Aim Although inflammation‐based markers in cancer have been used for prognostic
prediction, the most useful marker for hepatocellular carcinoma (HCC) has not been …

Background Recurrence of hepatocellular carcinoma (HCC) after curative resection remains
a major cause of treatment failure and tumor-related death. Patterns of HCC recurrence can …

Background Inflammation plays a significant role in tumour development, progression, and
metastasis. In this study, we focused on comparing the predictive potential of inflammatory …

Purposes The present study investigated the prognostic value of inflammation-based
prognostic scores in patients with hepatocellular carcinoma (HCC) who underwent …

Background The prognosis of hepatocellular carcinoma (HCC) is not optimistic. Our study
focused on present inflammatory markers, including the neutrophil-to-lymphocyte ratio …

Purpose Our study aimed to identify inflammatory biomarkers and develop a prediction
model to stratify high-risk patients for hepatitis B virus-associated hepatocellular carcinoma …

Background Various inflammation‐based prognostic scores, including the G lasgow
prognostic score (GPS), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio …

Objective To assess and compare the predictive values of the hepatic Glasgow Prognostic
Score (hGPS) and Cancer of the Liver Italian Program (CLIP) score in patients undergoing …